TRX CARDIAC LIMITED
Get an alert when TRX CARDIAC LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
—
Latest balance sheet
Net assets
-£2.4m
0% vs 2024
Employees
—
Average over period
Profit before tax
-£41k
+94.3% vs 2024
Watchouts
Facts from the Companies House register and the latest accounts — not a rating
-
Material uncertainty over going concern
This indicates the existence of a material uncertainty which may cast doubt over the Company's ability to continue as a going concern. The Directors are satisfied that Tissue Regenix Group Limited is capable of providing the necessary financial support and that the Company will be able to continue in operation for at least the next twelve months from the date of approval of the financial statements.
-
Going-concern uncertainty disclosed
-
Negative shareholders' funds
Net assets
3-year trend · vs Health Care median
Accounts
3-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|---|
| Turnover | £86,000 | £85,000 | — | — | |
| Operating profit | £59,000 | -£714,000 | — | — | |
| Profit before tax | £59,000 | -£714,000 | -£41,000 | +94.3% | |
| Net profit | £59,000 | -£714,000 | -£41,000 | +94.3% | |
| Cash | — | — | — | — | |
| Total assets less current liabilities | -£1,641,000 | -£2,355,000 | -£2,355,000 | 0% | |
| Net assets | -£1,641,000 | -£2,355,000 | -£2,355,000 | 0% | |
| Equity | — | — | -£2,355,000 | — | |
| Average employees | — | — | — | — | |
| Wages | — | — | — | — | |
| Directors' remuneration | — | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Operating margin | 68.6% | — | — | |
| Net margin | 68.6% | — | — | |
| Gearing (liabilities / total assets) | 333.1% | — | — |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Margin ratios are hidden where reported turnover is too small relative to profit to yield a meaningful figure — typical of holding companies whose income is mostly subsidiary dividends rather than trading revenue. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- RSM UK Audit LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Material uncertainty disclosed
“This indicates the existence of a material uncertainty which may cast doubt over the Company's ability to continue as a going concern. The Directors are satisfied that Tissue Regenix Group Limited is capable of providing the necessary financial support and that the Company will be able to continue in operation for at least the next twelve months from the date of approval of the financial statements.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 12 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| LUND, Kirsten Mary | Secretary | 2019-12-20 | — | — |
| LECOQUE, Jay Charles | Director | 2025-09-04 | Nov 1962 | American |
| LUND, Kirsten Mary | Director | 2025-10-16 | Nov 1983 | British |
Show 12 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DEVLIN, Paul John | Secretary | 2017-01-06 | 2018-01-31 |
| JONES, Gareth Hywel | Secretary | 2018-10-29 | 2019-12-20 |
| BARKER, Michael Denis | Director | 2019-08-28 | 2019-11-30 |
| COCKE, David Claiborne | Director | 2021-01-21 | 2025-07-31 |
| COULDWELL, Steven Ashley | Director | 2017-11-02 | 2019-07-31 |
| DEVLIN, Paul John | Director | 2017-01-09 | 2018-01-31 |
| GLENN, Jonathan Martin | Director | 2020-04-01 | 2025-09-05 |
| JEFFERSON, Ian David | Director | 2011-10-13 | 2016-11-21 |
| JONES, Gareth Hywel | Director | 2018-10-29 | 2020-11-24 |
| LEE, Daniel Ray | Director | 2020-11-16 | 2025-10-15 |
| ODELL, Antony Ruben | Director | 2011-10-13 | 2017-10-31 |
| SAMUEL, John Andrew Walter | Director | 2011-10-13 | 2020-03-20 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Tissue Regenix Limited | Corporate entity | Shares 75–100% | 2016-04-06 | Active |
Filing timeline
Last 20 of 69 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-07-12 | AA | accounts | Accounts with accounts type full | |
| 2026-01-05 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2025-11-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-11-03 | AP01 | officers | Appoint person director company with name date | |
| 2025-11-03 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-11 | AP01 | officers | Appoint person director company with name date | |
| 2025-09-11 | TM01 | officers | Termination director company with name termination date | |
| 2025-08-20 | AA | accounts | Accounts with accounts type full | |
| 2025-08-05 | TM01 | officers | Termination director company with name termination date | |
| 2024-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-04-03 | AA | accounts | Accounts with accounts type full | |
| 2023-10-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-03-28 | AA | accounts | Accounts with accounts type full | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2023-01-31 | MR01 | mortgage | Mortgage create with deed with charge number charge creation date | |
| 2022-10-28 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-09-20 | AA | accounts | Accounts with accounts type full | |
| 2021-11-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-09-25 | AA | accounts | Accounts with accounts type full | |
| 2021-02-03 | AP01 | officers | Appoint person director company with name date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 9
- Capital events
- 0
- Officers appointed
- 2
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.